These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30226808)

  • 1. Long noncoding RNA LINC00261 induces chemosensitization to 5-fluorouracil by mediating methylation-dependent repression of DPYD in human esophageal cancer.
    Lin K; Jiang H; Zhuang SS; Qin YS; Qiu GD; She YQ; Zheng JT; Chen C; Fang L; Zhang SY
    FASEB J; 2019 Feb; 33(2):1972-1988. PubMed ID: 30226808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA HOTAIR-mediated MTHFR methylation inhibits 5-fluorouracil sensitivity in esophageal cancer cells.
    Zhang S; Zheng F; Zhang L; Huang Z; Huang X; Pan Z; Chen S; Xu C; Jiang Y; Gu S; Zhao C; Zhang Q; Shi G
    J Exp Clin Cancer Res; 2020 Jul; 39(1):131. PubMed ID: 32653028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation.
    Li N; Zhao Z; Miao F; Cai S; Liu P; Yu Y; Wang B
    Cancer Gene Ther; 2021 May; 28(5):471-485. PubMed ID: 33199829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation of DPYD promoter, DPYD expression, and cellular sensitivity to 5-fluorouracil in cancer cells.
    Noguchi T; Tanimoto K; Shimokuni T; Ukon K; Tsujimoto H; Fukushima M; Noguchi T; Kawahara K; Hiyama K; Nishiyama M
    Clin Cancer Res; 2004 Oct; 10(20):7100-7. PubMed ID: 15501990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of the DPYD promoter region is not a major predictor of severe toxicity in 5-fluorouracil based chemotherapy.
    Amstutz U; Farese S; Aebi S; Largiadèr CR
    J Exp Clin Cancer Res; 2008 Oct; 27(1):54. PubMed ID: 18937829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
    Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
    IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of DPYD expression in RKO cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression.
    Zhang X; Soong R; Wang K; Li L; Davie JR; Guarcello V; Diasio RB
    Biochem Cell Biol; 2007 Jun; 85(3):337-46. PubMed ID: 17612628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil.
    Li LH; Dong H; Zhao F; Tang J; Chen X; Ding J; Men HT; Luo WX; Du Y; Ge J; Tan BX; Cao D; Liu JY
    Eur J Cancer; 2013 May; 49(7):1752-60. PubMed ID: 23313143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer.
    Kato H; Sato M; Naiki-Ito A; Inaguma S; Sano M; Komura M; Nagayasu Y; Xiaochen K; Kato A; Matsuo Y; Ijichi H; Takahashi S
    Cancer Med; 2024 Aug; 13(16):e70124. PubMed ID: 39158384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone H3K27 Trimethylation Modulates 5-Fluorouracil Resistance by Inhibiting PU.1 Binding to the DPYD Promoter.
    Wu R; Nie Q; Tapper EE; Jerde CR; Dunlap GS; Shrestha S; Elraiyah TA; Offer SM; Diasio RB
    Cancer Res; 2016 Nov; 76(21):6362-6373. PubMed ID: 27578004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients.
    Ezzeldin HH; Lee AM; Mattison LK; Diasio RB
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8699-705. PubMed ID: 16361556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients.
    Savva-Bordalo J; Ramalho-Carvalho J; Pinheiro M; Costa VL; Rodrigues A; Dias PC; Veiga I; Machado M; Teixeira MR; Henrique R; Jerónimo C
    BMC Cancer; 2010 Sep; 10():470. PubMed ID: 20809970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.
    Jin YY; Chen QJ; Xu K; Ren HT; Bao X; Ma YN; Wei Y; Ma HB
    Mol Cell Biochem; 2016 Nov; 422(1-2):161-170. PubMed ID: 27644195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription.
    Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H
    Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371
    [No Abstract]   [Full Text] [Related]  

  • 15. Nicotinamide N-methyltransferase decreases 5-fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect.
    Cui Y; Yang D; Wang W; Zhang L; Liu H; Ma S; Guo W; Yao M; Zhang K; Li W; Zhang Y; Guan F
    Mol Carcinog; 2020 Aug; 59(8):940-954. PubMed ID: 32367570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic profiling of DPYD variations relevant to 5-fluorouracil sensitivity using real-time cellular analysis and in vitro measurement of enzyme activity.
    Offer SM; Wegner NJ; Fossum C; Wang K; Diasio RB
    Cancer Res; 2013 Mar; 73(6):1958-68. PubMed ID: 23328581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived extracellular vesicles confer 5-fluorouracil resistance in esophageal cancer via long noncoding RNA AC116025.2 delivery.
    Zhang S; Liu S; Ren J; Zhang H; Chen S; Chen Y; Zhang S; Chen W; Xu C; Zhong S; Liu S; Lin C
    Mol Carcinog; 2022 Dec; 61(12):1177-1190. PubMed ID: 36239547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues.
    Hirota T; Date Y; Nishibatake Y; Takane H; Fukuoka Y; Taniguchi Y; Burioka N; Shimizu E; Nakamura H; Otsubo K; Ieiri I
    Lung Cancer; 2012 Jul; 77(1):16-23. PubMed ID: 22306127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior antitumour activity of S-1 in tumours with a high dihydropyrimidine dehydrogenase activity.
    Fujiwara H; Terashima M; Irinoda T; Takagane A; Abe K; Nakaya T; Yonezawa H; Oyama K; Takahashi M; Saito K; Takechi T; Fukushima M; Shirasaka T
    Eur J Cancer; 2003 Nov; 39(16):2387-94. PubMed ID: 14556932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.
    Watanabe T; Oba T; Tanimoto K; Shibata T; Kamijo S; Ito KI
    PLoS One; 2021; 16(6):e0252822. PubMed ID: 34101751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.